Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 52Ovarian Neoplasms 40Multiple Myeloma 20Fallopian Tube Neoplasms 13Lymphoma 12Sarcoma 11Carcinoma, Ovarian Epithelial 11Triple Negative Breast Neoplasms 8Recurrence 8Lymphoma, Large B-Cell, Diffuse 8Neoplasms 7Lymphoma, Non-Hodgkin 7Hodgkin Disease 6Neoplasms, Plasma Cell 5Sarcoma, Ewing 4Prostatic Neoplasms 4Neoplasm Metastasis 4Lymphoma, Mantle-Cell 4Burkitt Lymphoma 4Rhabdomyosarcoma 3Osteosarcoma 3Lymphoma, T-Cell, Peripheral 3Leiomyosarcoma 3Breast Neoplasms, Male 3Uterine Cervical Neoplasms 2Solid Tumors 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, T-Cell 2

Interventions

Specimen Handling 3Paclitaxel 3Nivolumab 3Carboplatin 3olaparib 2X-Rays 2Biopsy 2sargramostim 1pembrolizumab 1pazopanib 1pamiparib 1liposomal doxorubicin 1durvalumab 1ceralasertib 1cediranib 1atezolizumab 1apatinib 1Trabectedin 1Tissue Banks 1TIC10 compound 1Minimally Invasive Surgical Procedures 1Magnetic Resonance Spectroscopy 1LY-2157299 1Indocyanine Green 1Immunoglobulin G 1Gemcitabine 1Cyclophosphamide 1Colony-Stimulating Factors 1Cisplatin 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinosarcoma × liposomal doxorubicin × Clear all
NCT00815945 2017-02-14

Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors

AGO Study Group

Phase 2 Completed
41 enrolled
Sarcoma

Carcinosarcoma, Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡